Tuesday, October 21, 2008

Journal of Commercial Biotechnology — October 2008

Journal of Commercial Biotechnology — October 2008

The July 2008 issue of the Journal of Commercial Biotechnology is now available. The links below will take you to the abstract for each paper:
Volume 14, Issue 4
Continuing education in biotechnologyYali Friedman
Open content textbooks: Educating the next generation of bioentrepreneurs in developing economiesArlen D Meyers, Donald J McCubbrey and Richard T Watson
Can compliance help marketing and business development?John Avellanet
Money for nothing? Risks in biopharmaceutical companies from the perspective of public financiersLaura Heinonen and Birgitta Sandberg
Got value? Determine it. Demonstrate it. Communicate it. Realise itMitch DeKoven, Elisabeth H Hazard, Erica Goldberg and Shibani Pokras
Value-driven project and portfolio management in the pharmaceutical industry: Drug discovery versus drug development – Commonalities and differences in portfolio management practiceKerstin M Bode-Greuel and Klaus J Nickisch
Legal and Regulatory Update
Intellectual Property and Biotechnology: Biological InventionsStefan M Miller
Commercializing Successful Biomedical TechnologiesArlen D Meyers
Enterprise for Life Scientists: Developing Innovation and Entrepreneurship in the BiosciencesArlen D Meyers
Biotechnology and the LawEdward L Korwek
Welcome to Biotech NationJames Rogers
The Regulatory Challenge of BiotechnologyJohn Avellanet
Best Practices in Biotechnology Business DevelopmentHans-Erik Hamid Lydecker
Genetic Glass Ceilings: Transgenics for Crop BiodiversityDrew L Kershen

No comments: